Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.0437 | 0.0416 |
Onchocerca volvulus | Putative DNA topoisomerase 2, mitochondrial | 0.0191 | 0.4822 | 0.5 |
Plasmodium falciparum | DNA gyrase subunit B | 0.0165 | 0.3748 | 0.4068 |
Loa Loa (eye worm) | hypothetical protein | 0.0115 | 0.1703 | 0.1906 |
Mycobacterium tuberculosis | DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (type II DNA topoisomerase) | 0.0165 | 0.3748 | 0.5 |
Plasmodium vivax | DNA topoisomerase II, putative | 0.0283 | 0.8581 | 1 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.0084 | 0.0434 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0168 | 0.3868 | 0.4454 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0165 | 0.3748 | 0.4068 |
Entamoeba histolytica | DNA topoisomerase II, putative | 0.0283 | 0.8581 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0168 | 0.3868 | 0.4215 |
Plasmodium falciparum | DNA topoisomerase 2 | 0.0283 | 0.8581 | 1 |
Wolbachia endosymbiont of Brugia malayi | DNA gyrase, topoisomerase II, B subunit, GyrB | 0.0165 | 0.3748 | 1 |
Toxoplasma gondii | DNA topoisomerase 2, putative | 0.0283 | 0.8581 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0192 | 0.4833 | 0.559 |
Loa Loa (eye worm) | hypothetical protein | 0.0192 | 0.4833 | 0.559 |
Onchocerca volvulus | DNA topoisomerase 2 homolog | 0.0191 | 0.4822 | 0.5 |
Echinococcus multilocularis | DNA topoisomerase 2 alpha | 0.0283 | 0.8581 | 1 |
Brugia malayi | DNA gyrase/topoisomerase IV, A subunit family protein | 0.0283 | 0.8581 | 1 |
Plasmodium vivax | DNA gyrase subunit B, putative | 0.0165 | 0.3748 | 0.4068 |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0318 | 1 | 1 |
Onchocerca volvulus | DNA topoisomerase 2 homolog | 0.0191 | 0.4822 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.0434 | 0.0412 |
Treponema pallidum | DNA gyrase, subunit B (gyrB) | 0.0165 | 0.3748 | 1 |
Chlamydia trachomatis | DNA gyrase subunit B | 0.0165 | 0.3748 | 1 |
Echinococcus granulosus | small conductance calcium activated potassium | 0.0168 | 0.3868 | 0.4215 |
Chlamydia trachomatis | DNA gyrase subunit B | 0.013 | 0.2329 | 0.5718 |
Loa Loa (eye worm) | TOPoisomerase family member | 0.0283 | 0.8581 | 1 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0168 | 0.3868 | 0.4215 |
Trypanosoma brucei | DNA topoisomerase ii | 0.0318 | 1 | 1 |
Schistosoma mansoni | DNA topoisomerase II | 0.0283 | 0.8581 | 1 |
Echinococcus multilocularis | small conductance calcium activated potassium | 0.0168 | 0.3868 | 0.4215 |
Trichomonas vaginalis | DNA topoisomerase II, putative | 0.0283 | 0.8581 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0115 | 0.1703 | 0.1906 |
Giardia lamblia | DNA topoisomerase II | 0.0268 | 0.7977 | 0.5 |
Echinococcus granulosus | DNA topoisomerase 2 alpha | 0.0283 | 0.8581 | 1 |
Mycobacterium ulcerans | DNA gyrase subunit B | 0.0165 | 0.3748 | 1 |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0318 | 1 | 1 |
Brugia malayi | DNA topoisomerase II, alpha isozyme | 0.0283 | 0.8581 | 1 |
Schistosoma mansoni | calcium-activated potassium channel | 0.016 | 0.3532 | 0.3803 |
Brugia malayi | Probable DNA topoisomerase II | 0.0283 | 0.8581 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 0 % | Inhibitory activity against human T-lymphotropic virus type 1 (HTLV-1) infected HUT-102 cells at 10 microM. | ChEMBL. | 12617915 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.